RET and cancer: In particular, about 30% of pediatric cancers harbor BRAF/RAS mutations, while gene fusions are present in up to 60% of cases, mainly in younger patients with PTC, usually involving RET or NTRK1/3, as also ALK, BRAF and PPARG [8].